RARA and acute myeloid leukemia: These include the ZEB2 transcription factor essential for maintenance of leukemic growth in AML (Li et al., 2017), LCN2 lipocalin whose ectopic expression promotes leukemogenesis (Chakraborty et al., 2012), and other genes previously linked to AML (RARA, CCND1, and NFKB1).